253 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A115180

Qurient
₩4,380.00-6.1%-7.1%₩155.4bn/aPS17.8xn/an/a

A338840

Y-Biologics
₩10,380.00-11.6%n/a₩153.3bn/an/an/an/a

A023910

Daihan PharmaceuticalLtd
₩26,050.00-0.8%-5.8%₩153.2b₩36,000.00PE5.1xE1.2%2.9%

A217950

PHARMARESEARCH BIO
₩35,400.00-1.0%61.6%₩143.3bn/an/an/an/a

A065660

Anterogen.Co.Ltd
₩14,680.001.8%4.4%₩142.9bn/aPS21.5xn/an/a

A106190

High Tech Pharm
₩13,060.00-6.7%22.8%₩138.9bn/aPE10.3xn/a0.8%

A002620

Jeil Pharma Holdings
₩8,930.000.8%-11.5%₩137.1bn/aPB0.4xn/a0.6%

A046210

HLB PANAGENE
₩3,180.00-7.3%-16.1%₩134.2bn/an/an/an/a

A284620

Kainos Medicine
₩4,635.00-0.5%27.9%₩130.6bn/an/an/an/a

A009300

Sam-A Pharm
₩21,350.00-3.8%31.1%₩130.3bn/aPE5.3xn/a3.5%

A042520

HansBiomed
₩9,960.00-1.9%-44.5%₩129.4bn/aPS1.6xn/a0%

A348150

KoBioLabs
₩6,600.000%-29.6%₩127.9bn/aPS2.5xn/an/a

A191420

TegoScience
₩15,750.000.8%82.9%₩126.1bn/aPE37.6xn/an/a

A251120

BIO-FD&CLtd
₩14,490.00-0.7%7.0%₩126.0bn/aPE24.4xn/an/a

A183490

Enzychem Lifesciences
₩1,553.003.5%3.2%₩124.3bn/aPS1.5xn/an/a

A299660

Cellid
₩5,830.00-9.0%29.4%₩123.0bn/aPS134.6xn/an/a

A378800

Shaperon
₩4,065.006.6%-7.8%₩122.5bn/aPS1343xn/an/a

A004310

Hyundai Pharmaceutical
₩4,380.00-8.9%16.6%₩121.2bn/an/an/a0.8%

A054670

Daehan New Pharm
₩8,470.00-1.7%-3.8%₩118.9bn/an/an/a1.2%

A061250

Hwail PharmaceuticalLtd
₩1,573.00-1.9%-24.9%₩118.5bn/an/an/an/a

A003120

Ilsung Is
₩16,680.00-0.6%-21.3%₩116.2bn/aPS1.6xn/a9.0%

A388870

Pharos iBio
₩8,880.00-8.8%-37.0%₩114.7bn/aPB5xn/an/a

A314130

Genome
₩3,750.00-1.1%-46.8%₩114.6bn/aPS4.8xn/an/a

A464280

Tdspharm
₩20,700.00-33.7%n/a₩114.5bn/an/an/an/a
Page 6 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.